Gonorrhea Treatment Drugs Market Analysis

The market is segmented by treatment into monotherapy and dual therapy, out of which, the dual therapy segment is anticipated to hold the largest share in the gonorrhea treatment market on account of increasing preference of this therapy over monotherapy for treating symptomatic and asymptomatic gonorrhea, and the rising adoption of the treatment regime globally. Moreover, as dual therapy with azithromycin and ceftriaxone is considered to be as the first-line regimen for treating gonorrhea, the segment is anticipated to also witness noteworthy growth in the forecast period. Additionally, on the basis of distribution channel, the segment for hospital pharmacies is evaluated to occupy the largest market share during the forecast period. This can be credited to the ease to receive prescribed medicines from the hospital facility itself.

Our in-depth analysis of the global market includes the following segments